Edwards Lifesciences (EW) Experiences Rubust Heart Valve Sales, Analyst Sees Upside

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/15/2026

1. IBM
2. SPY
3. LCID
4. JPM
5. ERAS
6. BAC
7. TREX
8. AAPL
9. ORCL
10. SKHY

Go back to Edwards Lifesciences (EW) Experiences Rubust Heart Valve Sales, Analyst Sees Upside

Edwards Lifesciences Corp. (EW) Tops Q4 EPS by 13c; Guides Q1, FY13

February 4, 2013 4:02 PM EST

Edwards Lifesciences Corp. (NYSE: EW) reported Q4 EPS of $0.90, $0.13 better than the analyst estimate of $0.77. Revenue for the quarter came in at $510.5 million versus the consensus estimate of $499.46 million.

Edwards Lifesciences Corp. sees FY2013 EPS of $3.21-3.31, versus the consensus of $3.27. Edwards... More